In vitro efficacy of N-acetylcysteine on bacteria associated with chronic suppurative otitis media
Authors:
- Jane LeaJLJane Lea
- Anne Elizabeth ConlinACAnne Elizabeth Conlin
- Inna SekirovISInna Sekirov
- Veronica RestelliVRVeronica Restelli
- Komathi G AyakarKAKomathi G Ayakar
- LeeAnn TurnbullLTLeeAnn Turnbull
- Patrick DoylePDPatrick Doyle
- Michael NobleMNMichael Noble
- Robert RennieRRRobert Rennie
- William E SchreiberWSWilliam E Schreiber
- Brian D WesterbergBWBrian D Westerberg
Open Access
- 1 January 2014
- journal article
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 43 (1) , 20
Abstract
Background: The safety and efficacy of Ciprodex® has been demonstrated for treatment of chronic suppurative otitis media (CSOM). However, symptoms fail to resolve in 9-15% of patients. The objective of this study is to evaluate the efficacy of N-acetylcysteine (NAC) on S. aureus, and planktonic and sessile (biofilm forming) P. aeruginosa in vitro using clinical isolates from patients with CSOM. Methods: 1) Stability was assessed using liquid chromatography-mass spectrometry for each component in a prepared mixture of Ciprodex® and NAC over 15 days. Sterility was assessed by measuring bacterial growth on a blood agar plate. Efficacy was assessed using a disc diffusion method by inoculating plates with S. aureus ATCC 29513 and P. aeruginosa ATCC 27853, and measuring the clearance zone. 2) Fifteen P. aeruginosa strains were isolated from patients with CSOM and tested in vitro using the bioFILM PA™ antimicrobial susceptibility assay. Treatment solutions included Ciprodex® & ciprofloxacin +/- NAC, and NAC alone (0.25%, 0.5% & 1.25%). Results: 1) NAC combined with Ciprodex® demonstrated stability, sterility, and efficacy over a two-week period 2) P. aeruginosa strains in the sessile (33%-40%) and planktonic (13%) state demonstrated resistance to Ciprodex® and ciprofloxacin. When NAC ≥0.5% was used in isolation or as an adjunct to either of these medications, no resistance was found in the sessile or planktonic state among all 15 strains. Conclusion: 1) Ciprodex® combined with NAC has a shelf life of at least two weeks given the documented preservation of stability, sterility, and clinical efficacy of the mixed compounds. 2) P. aeruginosa strains demonstrated resistance to both Ciprodex® and ciprofloxacin. NAC ≥0.5% overcomes issues with resistance and shows promise in the treatment of CSOM.Keywords
This publication has 25 references indexed in Scilit:
- The role of intratympanic lactate injection in the prevention of cisplatin‐induced ototoxicityThe Laryngoscope, 2010
- N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosaBMC Microbiology, 2010
- Current Bacteriology of Suppurative OtitisOtology & Neurotology, 2009
- Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspension for the Topical Treatment of Ear InfectionsThe Pediatric Infectious Disease Journal, 2009
- N-Acetylcysteine as an Adjunct for Refractory Ear InfectionsOtology & Neurotology, 2007
- Effect of Ototopical Medications on Tympanostomy Tube BiofilmsThe Laryngoscope, 2007
- Biofilms in Ear, Nose, and Throat Infections: How Important are They?The Laryngoscope, 2007
- Effect of N-acetylcysteine on the Incidence of Recurrence of Otitis Media with Effusion and Re-insertion of Ventilation TubesActa Oto-Laryngologica, 2000
- Microbiology of chronic suppurative otitis media in childrenThe Pediatric Infectious Disease Journal, 1986
- Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.BMJ, 1979